Contract facts
FederalNIAID VRC is a federal award for Nih Nci held by Leidos Biomedical Research, Inc. Estimated value $125.8M ($95.3M obligated). Current period of performance ends Nov 29, 2024. Last award drew 1 bidder. Place of performance: FREDERICK, MD.
Recompete timing
PublicCurrent PoP ended Nov 29, 2024 (630 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordLeidos Biomedical Research, Inc — $2.1B obligated across 186 awards (firm-wide, all agencies).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N91020F00006?
75N91020F00006 (NIAID VRC) is a Nih Nci award with an estimated value of $125.8M, currently held by Leidos Biomedical Research, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N91020F00006?
Nih Nci awarded 75N91020F00006 to Leidos Biomedical Research, Inc.
Who is the incumbent on 75N91020F00006?
Leidos Biomedical Research, Inc is the incumbent with $2.1B across 186 related awards in SCOUT’s public footprint. The current period of performance ends Nov 29, 2024.
When does Leidos Biomedical Research, Inc’s 75N91020F00006 come up for recompete?
SCOUT tracks a period-of-performance end of Nov 29, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.